SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-013226
Filing Date
2018-09-13
Accepted
2018-09-13 17:26:34
Documents
27
Period of Report
2018-09-10
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 29773
2 ex99-1.htm EX-99.1 18608
3 ex99-2.htm EX-99.2 28995
4 image_001.jpg GRAPHIC 53074
5 image_002.jpg GRAPHIC 40897
6 image_003.jpg GRAPHIC 73952
7 image_004.jpg GRAPHIC 58745
8 image_005.jpg GRAPHIC 128937
9 image_006.jpg GRAPHIC 64082
10 image_007.jpg GRAPHIC 69067
11 image_008.jpg GRAPHIC 127997
12 image_009.jpg GRAPHIC 61160
13 image_010.jpg GRAPHIC 67229
14 image_011.jpg GRAPHIC 135971
15 image_012.jpg GRAPHIC 55486
16 image_013.jpg GRAPHIC 88960
17 image_014.jpg GRAPHIC 64292
18 image_015.jpg GRAPHIC 42370
19 image_016.jpg GRAPHIC 72307
20 image_017.jpg GRAPHIC 101456
21 image_018.jpg GRAPHIC 72095
22 image_019.jpg GRAPHIC 60917
23 image_020.jpg GRAPHIC 79208
24 image_021.jpg GRAPHIC 61355
25 image_022.jpg GRAPHIC 47204
26 image_023.jpg GRAPHIC 40100
27 image_024.jpg GRAPHIC 204505
  Complete submission text file 0001493152-18-013226.txt   2658205
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Taxus Cardium Pharmaceuticals Group Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33635 | Film No.: 181069584
SIC: 2836 Biological Products, (No Diagnostic Substances)